- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
GRF
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Grifols, S.A. · Healthcare · Drug Manufacturers - General
Latest close
10.14 EUR
0.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 5.6% above the Trend Line and sits at 37.4% of its 52-week range. The latest completed week returned 0.8%, after a 13.7% four-week move. The latest news-sentiment score is 50/100.
Setup score
50
out of 100
Latest Close
10.14 EUR
7 Aug 2026
1W Return
0.8%
latest completed week
4W Return
13.7%
short-term follow-through
12W Return
12.2%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
13.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.8%
Latest completed week; four-week move 13.7%.
Indicator stack
14/79
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 5.6% above the Trend Line and sits at 37.4% of its 52-week range. The latest completed week returned 0.8%, after a 13.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 13.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 13.7% over four weeks, 12.2% over 12 weeks, and -20.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.96Latest activity-pressure read.
Pressure change150.4%Four-week change in activity pressure.
Leadership-21.58Latest relative-leadership reading.
RS change33.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
1 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-21.5%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+7.6%Week of 17 Apr.
Worst week-8.9%Week of 13 Mar.
Latest week+0.8%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains9
Flat weeks0
Modest losses7
Sharp losses5
Recent vol2.7%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank9 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Drug Manufacturers - General
4-week rank1 / 17
Group average3.5%
Trend breadth70.6%
Trend70.6%active weekly trend signals
MD88.2%positive activity pressure
RS11.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape41/100
Trend, activity pressure, participation, and risk combine to a 41/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
Is Grifols (BME:GRF) A Bargain On Mixed Half Year Earnings? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 10.14 EUR | 0.8% | 9.60 EUR | 10.20 EUR | 0.96 | -21.58 | 580 | Off |
| 31 Jul 2026 | 10.06 EUR | 4.8% | 9.64 EUR | 10.22 EUR | 0.68 | -20.78 | 0 | Off |
| 24 Jul 2026 | 9.60 EUR | 5.7% | 9.68 EUR | 10.24 EUR | 0.50 | -25.30 | 0 | Off |
| 17 Jul 2026 | 9.08 EUR | 1.8% | 9.73 EUR | 10.26 EUR | 0.41 | -29.12 | 0 | Off |
| 10 Jul 2026 | 8.92 EUR | -1.8% | 9.79 EUR | 10.29 EUR | 0.38 | -32.44 | 0 | Off |
| 3 Jul 2026 | 9.09 EUR | 0.6% | 9.85 EUR | 10.31 EUR | 0.36 | -32.80 | 0 | Off |
| 26 Jun 2026 | 9.03 EUR | 0.6% | 9.91 EUR | 10.33 EUR | 0.23 | -32.17 | 0 | Off |
| 19 Jun 2026 | 8.97 EUR | 0.6% | 9.96 EUR | 10.34 EUR | 0.08 | -34.40 | 0 | Off |
| 12 Jun 2026 | 8.92 EUR | -0.9% | 10.00 EUR | 10.36 EUR | -0.07 | -32.59 | 0 | Off |
| 5 Jun 2026 | 9.00 EUR | -4.2% | 10.05 EUR | 10.37 EUR | -0.27 | -30.61 | 0 | Off |
| 29 May 2026 | 9.39 EUR | -0.9% | 10.10 EUR | 10.39 EUR | -0.52 | -28.84 | 0 | Off |
| 22 May 2026 | 9.48 EUR | 5.0% | 10.16 EUR | 10.40 EUR | -0.75 | -26.56 | 0 | Off |
| 15 May 2026 | 9.03 EUR | 2.3% | 10.22 EUR | 10.41 EUR | -0.97 | -28.87 | 0 | Off |
| 8 May 2026 | 8.83 EUR | 0.1% | 10.32 EUR | 10.42 EUR | -1.00 | -31.04 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.